课题基金 / 基金详情

Correlation to the chemosensitivity test and metallothionein immunostaining in head and neck squamous cell carcionoma

Correlation to the chemosensitivity test and metallothionein immunostaining in head and neck squamous cell carcionoma
头颈部鳞状细胞癌化疗敏感性试验与金属硫蛋白免疫染色的相关性
批准号:
09672079
负责人:
MURAMATSU Yasunori
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

MURAMATSU Yasunori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present study dealts with correlation to the chemosensitivity test and immunohistochemical scoring of metallothionein (MT) in a total 36 cased of squamous cell carcinoma in the oral cavity (n=23), pharynx (n=3), maxillary sinus (n=3), larynx (n=6) and esophagus (n=1). Mainly, chemosensitivity drug test were testing cisplatin (CDDP).Immunohistochemical evaluation of MT reaction in squamous cell carcinoma in the oral cavity has already been described including scoring of MT index that MT positive cell SCC localized either tumor cell or stromal cell. The study also notes correlation among CDDP sensitivity test and MT profiles and index including clinical outcom, pathological grading and chemotherapy with cisplatin or carboplatin and also radiation therapy. MT Immunoreactivity was expressed both tumor cell cytoplasm and nuclei, and showed heterogeneous localization In tuor epithelial cells and In the stroma. Histiocytic and fibrocytic cells in both peripheral and interstitial stromas were also not stained homegeneously.CDDP inhibition index (II) showed 50% or higher (n=17) that were sensitivity cases and 19 cases were less than 50% that were no sensitivity cases. MT positive cell index (PI), 14 cases were showed 15% or higher that were immunoreactivity cases and 22 cases were less than 15% that were no reactivity cases. In these, MT PI 15% or higher and CDDP II less than 50% were II cases, MTPI less than 15% and CDDP II 50% or higher were 14 cases. These finding suggest that correlation with CDDP drug sensitivity and MT immunoreactivity case were 25 of 36% cases (69.4%).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Y.Muramatsu,Y.Hasegawa,et.al: "Metallothionein Immunoreactivity In Head and Neck Carcinomas;Special Reference to Clinical Behaviors and Chemotherapiec Responses"Anticancer Research. 20. 1-8 (2000)
Y.Muramatsu、Y.Hasekawa 等人:“头颈癌中的金属硫蛋白免疫反应性;临床行为和化疗反应的特别参考”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Muramatsu, A.Kamegai et al: "Metallothionein Immunoreactivity In Head and Neck Carcinomas ; Special Reference to Clinical Behaviors and Chemotherapiec Responses"Anticancer Research. 20. 1-8 (2000)
Y.Muramatsu、A.Kamegai 等人:“头颈癌中的金属硫蛋白免疫反应性;临床行为和化疗反应的特别参考”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Muramatsu, Y.Hasegawa,et al.: "Mmetallothionein Immunoreactivity In Head and Neck Carcinomas ; Special Reference to Clinical Behaviors and Chemotherapiec Responses."Anticancer Research. 20. 1-8 (2000)
Y.Muramatsu、Y.Hasekawa 等人:“头颈癌中的金属硫蛋白免疫反应性;临床行为和化疗反应的特别参考。”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Muramatsu,A., Kamegai,et al.: "Histochemical characteristics of calcium binding S100 proteins and bone morphogenetic proteins in chondro-osseous tumors"Oncology Reports. 4. 849-853 (1997)
Muramatsu,A.、Kamegai 等人:“软骨骨肿瘤中钙结合 S100 蛋白和骨形态发生蛋白的组织化学特征”肿瘤学报告。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Gene expression of Oral Leukoplakia and Early Squamous Cell Carcinoma DNA Array Study
    • 批准号:
      14571925
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2002
    • 负责人:
      MURAMATSU Yasunori
    • 依托单位:
    海外基金